Marshall Wace Portfolio holdings
Marshall Wace is a British firm that runs long/short hedge funds. Its strategies combine computer-driven and traditional company analysis, applied worldwide and mostly to long/short equity. Paul Marshall, formerly head of European equities at Mercury Asset Management, and Ian Wace, formerly head of equities trading at Deutsche Bank, founded it in 1997. In 2002 it launched TOPS, a system that gathers investment ideas from equity professionals and uses algorithms to turn them into stock portfolios. In 2015 Marshall Wace formed a long-term partnership with KKR, a private equity and credit investor that took an ownership interest in the firm.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$71M |
| 2 |
Baxter International
BAX
|
+$60.7M |
| 3 |
T-Mobile US
TMUS
|
+$60.1M |
| 4 |
Perrigo
PRGO
|
+$53.7M |
| 5 |
NRG Energy
NRG
|
+$50.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$68.2M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$53.3M |
| 3 |
Avient
AVNT
|
+$45.7M |
| 4 |
EVHC
Envision Healthcare Holdings
EVHC
|
+$45.6M |
| 5 |
BHI
Baker Hughes
BHI
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.07% |
| 2 | Consumer Discretionary | 12.28% |
| 3 | Industrials | 12.1% |
| 4 | Technology | 11.2% |
| 5 | Financials | 10.46% |
Similar funds
Marshall Wace's Q4 2014 Portfolio in Review
As of Q4 2014, Marshall Wace held 1,154 positions worth $7.57B, up 9.3% from $6.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $235M of net new capital in Q4 2014, opening 301 new positions and adding to 231 existing holdings. Its largest new stake was Baxter International: 846,191 shares worth $62M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Alibaba, an estimated $68.2M trimmed.
- Marshall Wace's largest Q4 2014 buy was Baxter International: 846,191 shares worth $62M.
- Marshall Wace added most to Allergan Inc in Q4 2014, an estimated $71M increase.
- Marshall Wace's biggest Q4 2014 reduction was Alibaba, cutting an estimated $68.2M.
- Marshall Wace fully exited Baker Hughes in Q4 2014, selling an estimated $40.5M.
- Marshall Wace's ten largest holdings make up 16% of its $7.57B portfolio in Q4 2014.
- Marshall Wace opened 301 new positions and closed 370 in Q4 2014.
- Marshall Wace's portfolio value rose 9.3% quarter-over-quarter to $7.57B.
Based on Marshall Wace's 13F filing for Q4 2014, filed 17 Feb 2015.